To Evaluate the Efficacy & Safety of LuminoMark Injection in Patients With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04854304` - Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
Recruiting	`NCT01678170` - Clinical Application of Breast Blood-oxygen Functional Imaging Technology	N/A
Completed	`NCT00039780` - Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel	Phase 3
Completed	`NCT02909452` - Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors	Phase 1
Recruiting	`NCT04535466` - Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
Recruiting	`NCT01917279` - Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC	Phase 3
Recruiting	`NCT01427400` - The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction	Phase 4
Completed	`NCT05665894` - Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis
Not yet recruiting	`NCT04088110` - Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer	Phase 2
Terminated	`NCT02997540` - Effect of Body Position and Probe Position on the Localization of Breast Mass
Terminated	`NCT01140776` - Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy	N/A
Recruiting	`NCT04911101` - Performance Indicators and Patient Experience in 7G and 10G Vacuum-assisted Excision of Probably Benign Breast Lesions	N/A
Completed	`NCT04554316` - Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery	N/A
Suspended	`NCT04151368` - Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy	N/A
Recruiting	`NCT04605575` - Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer	Phase 2
Recruiting	`NCT05814224` - Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA	N/A
Not yet recruiting	`NCT06118996` - Breast 3DUS ABUS System Comparison	N/A
Completed	`NCT02452333` - Oncoplastic Approach to Excisional Breast Biopsies	N/A
Terminated	`NCT01372215` - Multi-Compression Spot Mammography	N/A
Completed	`NCT00299039` - T3AI-Pain After Breast Surgery	Phase 3

NCT number	NCT03743259
Study type	Interventional
Source	Hanlim Pharm. Co., Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	May 29, 2018
Completion date	April 22, 2019

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms